Back to search

Novel approaches to the treatment of cachexia

Data up to Jan 2025

Published2007
Citations74
References55

Total Citations Per Year

Abstract

References (55)

Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy

2001 • 3,292 citations

Heart-Lung Transplantation

2016 • 2,165 citations

Proteasome inhibitors: valuable new tools for cell biologists

1998 • 1,453 citations

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.

1991 • 1,209 citations

Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study

2003 • 704 citations

Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial

2003 • 590 citations

Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF‐κB‐independent, FoxO1‐dependent mechanism

2006 • 455 citations

THE IMMEDIATE CAUSES OF DEATH IN CANCER

1932 • 418 citations

Comparison of Orally Administered Cannabis Extract and Delta-9-Tetrahydrocannabinol in Treating Patients With Cancer-Related Anorexia-Cachexia Syndrome: A Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial From the Cannabis-In-Cachexia-Study-Group

2006 • 388 citations

The Influence of Thalidomide on the Clinical and Immunologic Manifestation of Erythema Nodosum Leprosum

1993 • 379 citations

Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial

2005 • 312 citations

The syndrome of cardiac cachexia

2002 • 299 citations

Double-Blind, Placebo-Controlled, Randomized Study of Eicosapentaenoic Acid Diester in Patients With Cancer Cachexia

2006 • 277 citations

Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lypopolysaccharide

2002 • 270 citations

Interleukin-15: a novel anabolic cytokine for skeletal muscle.

1995 • 259 citations

Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia

2007 • 257 citations

A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer

1990 • 238 citations

Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.

1993 • 227 citations

Effects of Dietary Omega-3 Fatty Acids on Human Breast Cancer Growth and Metastases in Nude Mice

1993 • 224 citations

Effect of ω-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer

1992 • 205 citations

Δ9 Tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells

1998 • 186 citations

The metabolic basis of cancer cachexia

1997 • 182 citations

Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control

2001 • 174 citations

Pharmacological Agents Affecting Emesis

1992 • 171 citations

Assessment of Tumor Necrosis Factor Alpha Blockade As an Intervention to Improve Tolerability of Dose-Intensive Chemotherapy in Cancer Patients

2006 • 168 citations

Anticachectic Effects of Formoterol

2004 • 159 citations

A Phase II Study with Antioxidants, Both in the Diet and Supplemented, Pharmaconutritional Support, Progestagen, and Anti-Cyclooxygenase-2 Showing Efficacy and Safety in Patients with Cancer-Related Anorexia/Cachexia and Oxidative Stress

2006 • 156 citations

Angiotensin II directly induces muscle protein catabolism through the ubiquitin–proteasome proteolytic pathway and may play a role in cancer cachexia

2005 • 136 citations

Metabolic Effects of Tumour Necrosis Factor-α (Cachectin) and Interleukin-1

1989 • 121 citations

Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients

1997 • 118 citations

Fish Oils Produce Anti-inflammatory Effects and Improve Body Weight in Severe Heart Failure

2006 • 117 citations

Megestrol acetate stimulates food and water intake in the rat: effects on regional hypothalamic neuropeptide Y concentrations

1994 • 113 citations

Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitro

1991 • 110 citations

Interleukin‐15 is able to suppress the increased DNA fragmentation associated with muscle wasting in tumour‐bearing rats

2004 • 104 citations

Body composition changes in patients with systolic heart failure treated with beta blockers: A pilot study

2005 • 92 citations

Cachexia: a therapeutic approach beyond cytokine antagonism

2002 • 88 citations

Interleukin-15 decreases proteolysis in skeletal muscle: A direct effect

2005 • 79 citations

Ghrelin, a Novel Growth Hormonereleasing Peptide, in the Treatment of Cardiopulmonaryassociated Cachexia

2006 • 71 citations

A Randomized, Placebo-Controlled Trial of Nandrolone Decanoate in Human Immunodeficiency Virus-Infected Men with Mild to Moderate Weight Loss with Recombinant Human Growth Hormone as Active Reference Treatment

2005 • 59 citations

Mechanism of lipid mobilization associated with cancer cachexia: Interaction between the polyunsaturated fatty acid, eicosapentaenoic acid, and inhibitory guanine nucleotide-regulatory protein

1993 • 57 citations

Therapy insight: use of melanocortin antagonists in the treatment of cachexia in chronic disease

2006 • 56 citations

Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting

2002 • 55 citations

A phase II randomized, placebo-controlled, double-blind study of the efficacy and safety of RC-1291 (RC) for the treatment of cancer cachexia

2007 • 52 citations

The effects of enalapril‐digoxin‐diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia

2001 • 44 citations

The Pharmacological Treatment of Cachexia

2004 • 44 citations

Effects of Recombinant Erythropoietin in Palliative Treatment of Unselected Cancer Patients

2004 • 41 citations

Erythropoietin attenuates cachectic events and decreases production of interleukin-6, a cachexia-inducing cytokine

2005 • 35 citations

Palliative treatment of cancer anorexia with oral suspension of megestrol acetate.

2003 • 35 citations

Effect of medroxyprogesterone acetate on the quality of life of the oncologic patient

1997 • 32 citations

The use of melanocortin antagonists in cachexia of chronic disease

2005 • 31 citations

Captopril inhibits the production of tumor necrosis factor-α by human mononuclear cells in patients with congestive heart failure

2001 • 26 citations

Ostarine increases lean body mass and improves physical performance in healthy elderly subjects: Implications for cancer cachexia patients

2007 • 20 citations

Effect of FR143430, a novel cytokine suppressive agent, on adenocarcinoma colon26-induced cachexia in mice.

1998 • 20 citations

Discovery of Corticotropin Releasing Factor 2 Receptor Selective Sauvagine Analogues for Treatment of Skeletal Muscle Atrophy

2004 • 14 citations

Thalidomide and cancer cachexia: old problem, new hope?

2005 • 12 citations

Cited By (0)

Loading...